Cargando…
A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function
BACKGROUND: Purified cannabidiol (CBD), a non-psychoactive phytocannabinoid, has gained regulatory approval to treat intractable childhood epilepsies. Despite this, artisanal and commercial CBD-dominant hemp-based products continue to be used by epilepsy patients. Notably, the CBD doses used in thes...
Autores principales: | Milligan, Carol J., Anderson, Lyndsey L., Bowen, Michael T., Banister, Samuel D., McGregor, Iain S., Arnold, Jonathon C., Petrou, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185959/ https://www.ncbi.nlm.nih.gov/pubmed/35689251 http://dx.doi.org/10.1186/s42238-022-00136-x |
Ejemplares similares
-
Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels
por: Milligan, Carol J., et al.
Publicado: (2023) -
Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2022) -
Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels
por: Heblinski, Marika, et al.
Publicado: (2020) -
Prescribing medicinal cannabis
por: Arnold, Jonathon C, et al.
Publicado: (2020) -
Fenestropathy of Voltage-Gated Sodium Channels
por: Gamal El-Din, Tamer M., et al.
Publicado: (2022)